Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trials

Medical device clinical trials from ClinicalTrials.gov

Trial RECRUITING

Atrial Flutter Ablation in the iCMR

NCT NCT05904548

Start 2024-06-20

View Details →

Trial COMPLETED

The Use of Smart Glasses for Environmental Controls

NCT NCT06932978

Start 2024-05-01

View Details →

Trial RECRUITING

The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMR

NCT NCT03142152

Start 2018-01-01

View Details →

Trial NOT_YET_RECRUITING

Facial Nerve Monitoring During Parotid and Facial Surgery Using a Non-Invasive Patch

NCT NCT07523373

Start 2026-05-01

View Details →

Trial RECRUITING

LONG NAGOMI™ PMCF STUDY

NCT NCT07399002

Start 2026-02-27

View Details →

Trial TERMINATED

iCLAS™ Cryoablation System Post-Market Clinical Follow-up (PMCF) Study

NCT NCT05416086

Start 2021-09-03

View Details →

Trial ACTIVE_NOT_RECRUITING

Edwards EVOQUE Eos MISCEND Study

NCT NCT02718001

Start 2015-02-06

View Details →

Trial NOT_YET_RECRUITING

Sequential FOLFOX-HAIC-TACE Plus Sintilimab-Bevacizumab Neoadjuvant Therapy Versus Direct Resection in Resectable High-Risk Recurrence Hepatocellular Carcinoma

NCT NCT07522411

Start 2026-04-30

View Details →

Trial ENROLLING_BY_INVITATION

Evaluation of Gadolinium Based Contrast Agents for Portable MR Imaging Systems

NCT NCT07296263

Start 2025-12-30

View Details →

Trial TERMINATED

The Nanowear Wearable Covid-19 Observational and Analysis Trend

NCT NCT04717024

Start 2020-09-15

View Details →

Trial RECRUITING

Intacs Prescription Inserts for Keratoconus Patients

NCT NCT02138669

Start 2011-01

View Details →

Trial RECRUITING

Pembrolizumab, Lenvatinib and IL-15 Superagonist N-803 in Combination With HER2 Targeting Autologous Dendritic Cell (AdHER2DC) Vaccine in Participants With Advanced or Metastatic Endometrial Cancer

NCT NCT06253494

Start 2024-05-14

View Details →

Page 333 of 417

↑